Chininum Sulphuricum Pellet
NDC Package 0220-1306-41

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Chininum Sulphuricum (quinine sulfate) pellets is a medication used alone or with other medication to treat malaria caused by mosquito bites in countries where malaria is common. This formulation utilizes a pellet delivery system. Marketed by Boiron, this product is identified by NDC 0220-1306.

Identification & Billing

NDC Package Code
0220-1306-41
Package Description
9 [hp_C] in 1 TUBE
Product Code
0220-1306
11-Digit Billing Format
00220130641

Clinical Specifications

Proprietary Name
Chininum Sulphuricum
Non-Proprietary Name
Quinine Sulfate
Substance Name
Quinine Sulfate
Dosage Form
Pellet - A small sterile solid mass consisting of a highly purified drug (with or without excipients) made by the formation of granules, or by compression and molding.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
QUININE SULFATE 9 [hp_C]/9[hp_C]
Pharmacologic Class
Antimalarial - [EPC] (Established Pharmacologic Class)
Usage Information
This medication is used alone or with other medication to treat malaria caused by mosquito bites in countries where malaria is common. Malaria parasites can enter the body through these mosquito bites, and then live in body tissues such as red blood cells or the liver. This medication is used to kill the malaria parasites living inside red blood cells. In some cases, you may need to take a different medication (such as primaquine) to kill the malaria parasites living in other body tissues. Both drugs may be needed for a complete cure and to prevent the return of infection (relapse). Quinine belongs to a class of drugs known as antimalarials. It is not used for the prevention of malaria. The United States Centers for Disease Control provide updated guidelines and travel recommendations for the prevention and treatment of malaria in different parts of the world. Discuss the most recent information with your doctor before traveling to areas where malaria occurs.

Regulatory & Marketing

Labeler Name
Boiron
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
Start Marketing Date
03-03-1983
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0220-1306-41 identifies a specific commercial package of 9 [hp_c] in 1 tube of Chininum Sulphuricum, a human over the counter drug labeled by Boiron. This pellet is formulated for oral use and contains quinine sulfate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Boiron on March 03, 1983. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is used alone or with other medication to treat malaria caused by mosquito bites in countries where malaria is common. Malaria parasites can enter the body through these mosquito bites, and then live in body tissues such as red blood cells or the liver. This medication is used to kill the malaria parasites living inside red blood cells. In some cases, you may need to take a different medication (such as primaquine) to kill the malaria parasites living in other body tissues. Both drugs may be needed for a complete cure and to prevent the return of infection (relapse). Quinine belongs to a class of drugs known as antimalarials. It is not used for the prevention of malaria. The United States Centers for Disease Control provide updated guidelines and travel recommendations for the prevention and treatment of malaria in different parts of the world. Discuss the most recent information with your doctor before traveling to areas where malaria occurs.

How is this Boiron product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00220130641. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0220-1306-41
11-Digit CMS (5-4-2)
00220-1306-41

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.